EverSlim review

Take a quarter dose here and you pay for a full one — "One flat price. No tiers" is EverSlim's own line, and it means the drug you skip is drug you bought. The larger problem is arithmetic you cannot do from the site at all. The same homepage advertises one pair of prices in its comparison table and a different pair on its ongoing-care card, and the plan you actually buy costs a third pair that appears on neither. Whichever figure you budgeted from, it is wrong. Give EverSlim real credit for the parts it does plainly: three named pharmacies, an exact list of which states get asynchronous care and which need a live visit first, no countdowns, no first-month bait, and prepay savings percentages that are true. It even discloses that the doctors in its ads may be actors. Price is the one thing it will not pin down.

Vs median

$45/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Flat at every dose

EverSlim names its pharmacy: EPIQ Scripts, Foothills Pharmacy, Emerald Compounding Pharmacy. No bloodwork is required before you start. A clinician review is included in the price.

EverSlim sells compounded semaglutide and tirzepatide in both injectable and oral form, dispensed by EPIQ Scripts, Foothills Pharmacy and Emerald Compounding Pharmacy. It serves all 50 states and DC and publishes exactly which 44 states get asynchronous care and which seven — DC, Kansas, Louisiana, Mississippi, New Mexico, Rhode Island and West Virginia — require a live consultation first. Pricing is month-to-month with three- and six-month prepay options, no first-month teaser, no scarcity badges and no strike-throughs. The complication is which price is real: the same homepage advertises two different pairs of figures for the same two products, and the plan you actually buy costs a third pair that appears on no marketing page.

ONE FLAT PRICE AT EVERY DOSE — "Two proven options. One flat price. No tiers, no upsells, no insurance games." A patient holding at a quarter dose pays exactly what a full-dose patient pays, and the difference is medicine bought and never used

• NO ADVERTISED FIGURE IS THE CHARGED FIGURE. The comparison table and hero say $113 and $136; the ongoing-care card on the same page says $127 and $183; the plan you buy costs $130 and $170. Whichever number you budgeted from, it is not the one on your card
• The flat-dose promise sits in the marketing copy alone — the plan itself carries no dose-price line in either direction, so the commitment is not repeated where you pay
• Refills ship automatically and the plan renews until you cancel
• Its product cards assert "16% average weight loss" for semaglutide and "22% average weight loss" for tirzepatide as flat claims
• The prepay ladder stops at six months — there is no annual rung
• No LegitScript seal of its own is displayed
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

EverSlim is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan